March 15 Revance Therapeutics Inc
* Revance therapeutics inc- on march 14, 2017 co entered into services agreement with ajinomoto althea, inc.- sec filing
* Revance therapeutics-under agreement,althea has agreed to provide co with future source of commercial fill/finish services for neuromodulator products
* Revance therapeutics inc- services agreement has an initial term that will expire in seven years
* Revance therapeutics- agreement provides co expanded capacity,second source of drug product manufacturing to support launch of daxibotulinumtoxina for injection (rt002) Source text for Eikon: Further company coverage:
ChargePoint secures $43 million in funding led by Siemens
SAN FRANCISCO, June 28 Electric vehicle charging station maker ChargePoint Inc said on Wednesday it had secured $43 million in financing led by German engineering group Siemens AG, bringing to a close the U.S. company's latest funding round at $125 million.
UK car output falls 10 pct in May ahead of new models
LONDON, June 29 British car production fell 9.7 percent in May as some major manufacturers reached the end of older product lines and prepared to begin building newer models, an industry body said on Thursday.